We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

77 hedge funds and large institutions have $45.8M invested in Cardiff Oncology in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,335% more call options, than puts

Call options by funds: $4.67M | Put options by funds: $325K

483% more capital invested

Capital invested by funds: $7.86M → $45.8M (+$38M)

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

40% more funds holding

Funds holding: 55 → 77 (+22)

7.36% more ownership

Funds ownership: 11.88% → 19.25% (+7.4%)

Holders
77
Holders Change
+22
Holders Change %
+40%
% of All Funds
1.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
17
Reduced
10
Closed
6
Calls
$4.67M
Puts
$325K
Net Calls
+$4.34M
Net Calls Change
+$4.33M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$1.82M
2
Marshall Wace
Marshall Wace
United Kingdom
+$1.15M
3
Goldman Sachs
Goldman Sachs
New York
+$760K
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$672K
5
BC
BIT Capital
Germany
+$628K

Top Sellers

1
BlackRock
BlackRock
New York
-$104K
2
Renaissance Technologies
Renaissance Technologies
New York
-$80.5K
3
Citadel Advisors
Citadel Advisors
Florida
-$73.8K
4
EP
Elkhorn Partners
Nebraska
-$70.4K
5
XT
XTX Topco
Cayman Islands
-$49.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAS
26
Point72 Asia (Singapore)
Singapore
$266K +$133K +49,892 New
CC
27
Callan Capital
California
$228K +$30.8K +11,600 +37%
Creative Planning
28
Creative Planning
Kansas
$215K +$39.2K +14,751 +58%
EP
29
Elkhorn Partners
Nebraska
$208K -$70.4K -26,500 -40%
Simplex Trading
30
Simplex Trading
Illinois
$200K +$99.9K +37,591 New
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$195K – – –
BHCM
32
Brevan Howard Capital Management
Jersey
$173K +$86.1K +32,402 New
CSS
33
Cubist Systematic Strategies
Connecticut
$172K +$85.8K +32,289 New
YIH
34
Y-Intercept (HK)
Hong Kong
$157K +$78.3K +29,464 New
Two Sigma Investments
35
Two Sigma Investments
New York
$123K -$20.5K -7,700 -25%
American Century Companies
36
American Century Companies
Missouri
$122K +$60.7K +22,824 New
IWC
37
Integrated Wealth Concepts
Massachusetts
$117K +$58.5K +22,000 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$116K -$46.5K -17,500 -45%
HighTower Advisors
39
HighTower Advisors
Illinois
$96K +$7.09K +2,667 +17%
Squarepoint
40
Squarepoint
New York
$93.5K +$46.5K +17,513 New
Wolverine Trading
41
Wolverine Trading
Illinois
$87.9K +$43.8K +16,467 New
Charles Schwab
42
Charles Schwab
California
$87.6K – – –
SPA
43
Sherbrooke Park Advisers
New York
$86.2K +$42.9K +16,148 New
FWS
44
FinDec Wealth Services
California
$85.4K – – –
UBV
45
United Bank (Virginia)
Virginia
$82.8K +$6.64K +2,500 +19%
AI
46
Atom Investors
Texas
$81.7K -$7.23K -2,722 -15%
GIA
47
Gladstone Institutional Advisory
Florida
$80.1K – – –
MTIM
48
Marathon Trading Investment Management
Pennsylvania
$80.1K +$39.9K +15,000 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$80K +$38.6K +14,534 +3,119%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$75.9K – – –
1
2
3 4

CRDF Hedge Fund Activity: Q1 2024 in Review

77 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2024, worth a combined $45.8M — up 483% from $7.86M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CRDF positions and 6 closed out — a net gain of 22 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.82M. The largest seller was BlackRock, cutting an estimated $104K.

  • 77 institutional investors held Cardiff Oncology (CRDF) as of Q1 2024, up from 55 in Q4 2023.
  • Funds reported $45.8M of Cardiff Oncology stock for Q1 2024, up 483% quarter-over-quarter.
  • 28 funds opened new Cardiff Oncology positions in Q1 2024 and 6 closed out, a net change of +22 holders.
  • The largest Cardiff Oncology buyer in Q1 2024 was Millennium Management, an estimated $1.82M added.
  • The largest Cardiff Oncology seller in Q1 2024 was BlackRock, an estimated $104K sold.

Based on aggregated 13F filings for Q1 2024.